Open AccessUnderstanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease
Author(s) -
Maria Barsky,
Joseph Meserve,
Helen Le,
Angelina Collins,
Siddharth Singh,
Brigid S. Boland,
William J. Sandborn,
Parambir S. Dulai
Publication year - 2020
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-020-06568-w
Subject(s) - colonoscopy , medicine , inflammatory bowel disease , hepatology , disease , gastroenterology , test (biology) , colorectal cancer , paleontology , cancer , biology
Evidence is now available in support of using fecal biomarkers to monitor disease activity in inflammatory bowel disease (IBD). Patient adherence is often cited as a barrier to implementation. We assessed patient determinants for using stool tests to monitor disease activity.